Article Information
History
- July 30, 2021.
Article Versions
- You are currently viewing Version 1 of this article (July 30, 2021 - 13:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Anna Sadnicka, MD PhD1,2,*,
- Lorenzo Rocchi, MD PhD1,3,
- Anna Latorre, MD PhD1,
- Elena Antelmi, MD PhD1,4,
- James Teo, MD PhD1,5,
- Isabel Pareés, MD PhD1,6,
- Britt S Hoffland, MD PhD1,7,
- Kristian Brock, PhD8,
- Katja Kornysheva, PhD9,
- Mark J Edwards, MD PhD1,2,
- Kailash P Bhatia, FRCP1 and
- John C Rothwell, PhD1
- 1Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK
- 2Movement Disorders and Neuromodulation Group, St George’s University of London, UK
- 3Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
- 4Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
- 5Department of Neurosciences, Kings College Hospital NHS Foundation Trust, London, UK
- 6Movement Disorders Program, Neurology Department, Hospital Ruber Internacional, Madrid, Spain
- 7Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands
- 8Cancer Research UK Clinical Trials Unit, University of Birmingham, UK
- 9School of Psychology, Bangor University, Wales, UK
- ↵*Corresponding author’s contact information
Anna Sadnicka. asadnick{at}sgul.ac.uk, Movement Disorders and Neuromodulation Group, St George’s University of London, UK.